Cellular responses to nanoparticles: Target structures and mechanisms

Nanotoxicology

Volumn 1, Issue 1, 2007, Pages 52-71

  Unfried, Klaus ^a   Albrecht, Catrin ^a   Klotz, Lars Oliver ^a   Von Mikecz, Anna ^a   Grether Beck, Susanne ^a   Schins, Roel P F ^a  

^a IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

Author keywords

DNA damage; Mitochondria; Nanoparticle uptake; Protein aggregation; Redox sensitive signalling; ROS generation

Indexed keywords

NANOMATERIAL; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE;

CELL FUNCTION; CELL INTERACTION; CELL MEMBRANE TRANSPORT; CELL NUCLEUS; CELL PROLIFERATION; CHEMICAL REACTION; DNA DAMAGE; ENDOCYTOSIS; GENOME ANALYSIS; HUMAN; LYSOSOME; MITOCHONDRION; MOLECULAR INTERACTION; NANOCHEMISTRY; NANOTECHNOLOGY; OXIDATION REDUCTION REACTION; PARTICLE SIZE; PARTICULATE MATTER; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SCREENING; SIGNAL TRANSDUCTION; SURFACE PROPERTY; TOXICITY TESTING;

EID: 34147160663     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.1080/00222930701314932     Document Type: Review

References (150)

1. Abdelmohsen K, Gerber PA, von Montfort C, Sies H, Klotz LO. 2003. Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43: Role of glutathione and tyrosine phosphatases. J Biol Chem 278:38360-38367.
2. Aderem A, Underhill DM. 1999. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17:593-623.
3. Albrecht C, Borm PJA, Unfried K. 2004. Signal transduction pathways relevant for neoplastic effects of fibrous and non-fibrous particles. Mut Res 553:59-65.
4. Ames BN. 1979. Identifying environmental chemicals causing mutations and cancer. Science 204:587-593.
5. Andreassen PR, Ho GP, D'Andrea AD. 2006. DNA damage responses and their many interactions with the replication fork. Carcinogenesis 27:883-892.
6. Barlow PG, Clouter-Baker A, Donaldson K, MacCallum J, Stone V. 2005. Carbon black nanoparticles induce type II epithelial cells to release chemotaxins for alveolar macrophages. Part Fibre Toxicol 2:11.
7. Barthel A, Klotz LO. 2005. Phosphoinositide 3-kinase signaling in the cellular response to oxidative stress. Biol Chem 386:207-216.
8. Beck-Speier I, Daynal N, Karg E, Maier Kl, Schumann G, Schulz H, Semmler M, Takenaka S, Stettmaier K, Bors W, et al. 2005. Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med 38:1080-1092.
9. Berken A, Abel J, Unfried K. 2003. Beta1-integrin mediates asbestos-induced phosphorylation of AKT and ERK1/2 in a rat pleural mesothelial cell line. Oncogene 22:8524-8528.
10. Berneburg M, Kamenisch Y, Krutmann J. 2006. Repair of mitochondrial DNA in aging and carcinogenesis. Photochem Photobiol Sci 5:190-198.
11. Blanchet S, Ramgolan K, Baulig A, Marano F, Baeza-Squiban A. 2003. Fine particulate matter induces amphiregulin secretion by bronchial epithelial cells. Am J Respir Cell Mol Biol 30:421-427.
12. Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J. 2006. The potential risk of nanomaterials: A review carried out for ECETOC. Part Fibre Toxicol 3:11.
13. Borm PJA., Cakmak G, Jermann E, Weishaupt C, Kempers P, van Schooten FJ, Oberdörster G, Schins RPF. 2005. Formation of PAH-DNA adducts after in vivo and in vitro exposure of rats and lung cells to different commercial CB types. Toxicol Appl Pharmacol 205:157-167.
14. Borm PJA, Schins RPF. 2006. Toxicological characterisation of engineered nanoparticles. In: Gupta RB, Kompella UB, editors. Nanoparticle technology for drug delivery. New York: Marcel Dekker Inc. p 161-197.
15. Brown DM, Donaldson K, Borm PJ, Schins RP, Denhardt M, Gilmour P, Jimenez LA, Stone V. 2004. Calcium and ROS-mediated activation of transcription factors and TNF-α cytokine gene expression in macrophages exposed to ultrafine particles. Am J Physiol Lung Cell Mol Biol 286:L344-353.
16. Cadenas E. 2004. Mitochondrial free radical production and cell signaling. Mol Aspects Med 25:17-26.
17. Campisi J. 2005. Senescent cells, tumour suppression, and organismal aging: good citizens, bad neighbours. Cell 120:513-522.
18. Chance B, Sies H, Boveris A. 1979. Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527-605.
19. 2 nanoparticles. Exp Cell Res 305:51-62.
20. Chnari E, Nikitczuk JS, Uhrich KE, Moghe PV. 2006a. Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL. Biomacromolecules 7:597-603.
21. Chnari E, Nikitczuk JS, Wang J, Uhrich KE, Moghe PV. 2006b. Engineered polymeric nanoparticles for receptor-targeted blockage of oxidized low density lipoprotein uptake and atherogenesis in macrophages. Biomacromolecules 7:1796-1805.
22. Clark EA, Brugge JS. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233-239.
23. Cremer T, Cremer C. 2001. Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nature Rev Genet 2:292-301.
24. Dellinger B, Pryor WA, Cueto R, Squadrito GL, Hegde V, Deutsch WA. 2001. Role of free radicals in the toxicity of airborne fine particulate matter. Chem Res Toxicol 14:1371-1377.
25. Devereux TR, Risinger JI, Barrett JC. 1999. Mutations and altered expression of the human cancer genes: What they tell us about causes. IARC Sci Publ 146:19-42.
26. Dobson J. 2006. Gene therapy progress and prospects: Magnetic nanoparticle-based gene delivery. Gene Ther 13:283-287.
27. Don Porto Carero A, Hoet PHM, Verschaeve L, Schoeters G, Nemery B. 2001. Genotoxic effects of carbon black particles, diesel exhaust particles, and urban air particulates and their extracts on a human alveolar epithelial cell line (A549) and a human monocytic cell line (THP-1). Environ Mol Mutagen 37:155-163.
28. Donaldson K, Beswick PH, Gilmour PS. 1996. Free radical activity associated with the surface of particles: A unifying factor in determining biological activity? Toxicol Lett 88:293-298.
29. Donaldson K, Stone V, Clouter A, Renwick L, MacNee W. 2001. Ultrafine particles. Occup Environ Med 58:211-216.
30. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJ. 2004. Nanotoxicology. Occup Environ Med 61:727-728.
31. Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, MacNee W, Stone V. 2005. Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure. Part Fibre Toxicol 2:10.
32. Driscoll KE, Howard BW, Carter JM, Janssen YM, Mossman BT, Isfort RJ. 2001. Mitochondrial-derived oxidants and quartz activation of chemokine gene expression. Adv Exp Med Biol 500:489-496.
33. Duffin R, Tran CL, Clouter A, Brown DM, MacNee W, Stone V, Donaldson K. 2002. The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Ann Occup Hyg 46(S 1):242-245.
34. Dugan LL, Turetsky DM, Du C, Lobner D, Wheeler M, Almli CR, Shen C K-F, Luh T-Y, Choi DW, Lin T-S. 1997. Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci USA 94:9434-9439.
35. Dybdahl M, Risom L, Bornholdt J, Autrup H, Loft S, Wallin H. 2004. Inflammatory and genotoxic effects of diesel particles in vitro and in vivo. Mutat Res 562:119-131.
36. Fang C, Shi B, Pei YY, Hong MH, Wu J, Chen HZ. 2006. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci 27:27-36.
37. Foged C, Brodin B, Frokjaer S, Sundblad A. 2005. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298:315-322.
38. Foley S, Crowley C, Smaihi M, Bonfils C, Erlanger BF, Seta P, Larroque C. 2002. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun 294:116-119.
39. Fubini B, Aust AE, Bolton RE, Borm PJA, Bruch J, Ciapetti G, Donaldson K, Elias Z, Gold J, Jaurand MC, et al. 1998. Non-animal tests for evaluating the toxicity of solid xenobiotics. ECVAM Workshop report 30. ATLA 26:579-617.
40. Fujishima A, Rao TN, Tryk DA. 2000. Titanium dioxide photocatalysis. J Photochem Photobiol C: Photochem Rev 1:1-21.
41. Garcion E, Lamprecht A, Heurtault B, Paillard A, Aubert-Pouessel A, Denizot B, Menei P, Benoit JP. 2006. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther 5:1710-1722.
42. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P. 2005. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113:1555-1560.
43. Gillet LC, Scharer OD. 2006. Molecular mechanisms of mammalian global genome nucleotide excision repair. Chem Rev 106:253-276.
44. Godbey WT, Wu KK, Mikos AG. 1999. Tracking and intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci USA 96:5177-5181.
45. Gorlich D. 1998. Transport into and out of the cell nucleus. EMBO J 17:2721-2727.
46. Gruenberg J. 2001. The endocytic pathway: A mosaic of domains. Nat Rev Mol Cell Biol 2:721-730.
47. Gupta AK, Curtis AS. 2004a. Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture. J Mater Sci Mater Med 15:493-496.
48. Gupta AK, Curtis AS. 2004b. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. Biomaterials 25:3029-3040.
49. Gupta AK, Gupta M. 2005. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26:1565-1573.
50. Gurr JR, Wang AS, Chen CH, Jan KY. 2005. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology 213:66-73.
51. Hall M, Grover PL. 1990. Polycyclic aromatic hydrocarbons: Metabolism, activation and tumor initiation. In: Cooper CS, Grover PL, editors. Chemical carcinogenesis and mutagenesis. Berlin: Springer Verlag. p 227-272.
52. Handwerger K, Gall JG. 2006. Subnuclear organelles: New insights into form and function. Trends Cell Biol 16:19-26.
53. Hartwig A. 2002. Role of DNA repair in particle- and fiber-induced lung injury. Inhal Toxicol 14:91-100.
54. Heckel K, Kiefmann R, Dorger M, Stoeckelhuber M, Goetz AE. 2004. Colloidal gold particles as a new in vivo marker of early acute lung injury. Am J Physiol Lung Cell Mol Physiol 287:L867-878.
55. Hoeijmakers JHJ. 2001. Genome maintenance mechanisms for preventing cancer. Nature 411:366-374.
56. Hoshino A, Fujioka K, Oku T, Nakamura S, Suga M. 2004. Quantum dots targeted to the assigned organelle in living cells. Microbiol Immunol 48:985-994.
57. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19:975-983.
58. Jia G, Wang H, Yan L, Wang X, Pei R, Yan T, Zhao Y, Guo X. 2005. Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol 39:1378-1383.
59. Jiang H, Nucifora FC, Ross CA, DeFranco DB. 2003. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Hum Mol Genet 12:1-12.
60. Kawanishi S, Hiraku Y, Murata M, Oikawa S. 2002. The role of metals in site-specific DNA damage with reference to carcinogenesis. Free Radic Biol Med 32:822-832.
61. Kessel M, Liu SX, Xu A, Santella R, Hei TK. 2002. Arsenic induces oxidative DNA damage in mammalian cells. Mol Cell Biochem 234-235:301-308.
62. Kim JS, Yoon TJ, Yu KN, Noh MS, Woo M, Kim BG, Lee KH, Sohn BH, Park SB, Lee JK, Cho MH. 2006. Cellular uptake of magnetic nanoparticle is mediated through energydependent endocytosis in A549 cells. J Vet Sci 7:321-326.
63. Kim Y-M, Reed W, Lenz AG, Jaspers I, Silbajoris R, Nick HS, Samet JM. 2005. Ultrafine carbon particles induce interleukin-8 gene transcription and p38 MAPK activation in normal human bronchial epithelial cells. Am J Physiol Lung Cell Lol Physiol 288:L432-441.
64. Klotz LO. 2002. Oxidant-induced signaling: Effects of peroxynitrite and singlet oxygen. Biol Chem 383:443-456.
65. Klotz LO, Sies H. 2003. Defenses against peroxynitrite: seleno-compounds and flavonoids. Toxicol Lett 140-141:125-132.
66. Knaapen AM, Borm PJA, Albrecht C, Schins RPF. 2004. Inhaled particles and lung cancer, part A. Mechanisms. Int J Cancer 109:799-809.
67. Konaka R, Kasahara E, Dunlap WC, Yamamoto Y, Chien KC, Inoue M. 1999. Irradiation of titanium dioxide generates both singlet oxygen and superoxide anion. Free Radic Biol Med 27:294-300.
68. Kopito R. 2000. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10:524-530.
69. Kumagai Y, Arimoto T, Shinyashiki M, Shimojo N, Nakai Y, Yoshikawa T, Sagai M. 1997. Generation of reactive oxygen species during interaction of diesel exhaust particle components with NADPH-cytochrome P450 reductase and involvement of the bioactivation in the DNA damage. Free Radic Biol Med 22:479-487.
70. Kuwano K, Hagimoto N, Nakanishi Y. 2004. The role of apoptosis in pulmonary fibrosis. Histol Histopathol 19:867-881.
71. Lee CG, Cho SJ, Kang MJ, Chapoval SP, Lee PJ, Noble PW, Yehualaeshet T, Lu B, Flavell RA, Milbrandt J, et al. 2004. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med 200:377-389.
72. Lesniak W, Bielinska AU, Sun K, Janczak KW, Shi X, Baker JR Jr, Balogh LP. 2005. Silver/dendrimer nanocomposites as biomarkers: fabrication, characterization, in vitro toxicity, and intracellular detection. Nano Lett 5:2123-2130.
73. Li H, Haberzettl P, Albrecht C, Höhr D, Knaapen AM, Borm PJA, Schins RPF. 2007. Inhibition of the mitochondrial respiratory chain function abrogates quartz induced DNA damage in lung epithelial cells. Mutat Res 617:46-57.
74. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, Wang M, Oberley T, Froines J, Nel A. 2003. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 111:455-460.
75. Limbach LK, Li Y, Grass RN, Brunner TJ, Hintermann MA, Muller M, Gunther D, Stark WJ. 2005. Oxide nanoparticle uptake in human lung fibroblasts: Effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol 39:9370-9376.
76. Lindahl T. 1993. Instability and decay of the primary struture of DNA. Nature 362:709-715.
77. Lohbach C, Neumann D, Lehr CM, Lamprecht A. 2006. Human vascular endothelial cells in primary cell culture for the evaluation of nanoparticle bioadhesion. J Nanosci Nanotechnol 6:3303-3309.
78. Luch A. 2005. Nature and nurture - lessons from chemical carcinogenesis. Nat Rev Cancer 5:113-125.
79. Mandavilli BS, Santos JH, Van Houten B. 2002. Mitochondrial DNA repair and aging. Mutat Res 509:127-151.
80. Marnett LJ. 2000. Oxyradicals and DNA damage. Carcinogenesis. 21:316-370.
81. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, Philbert MA, Ryan J, Seaton A, Stone V, et al. 2006. Safe handling of nanotechnology. Nature 444:267-269.
82. Mehta D, Bhattacharya J, Matthay MA, Malik AB. 2004. Integrated control of lung fluid balance. Am J Physiol Lung Cell Mol Physiol 287:L1081-1090.
83. Moghimi SM, Hunter AC, Murray JC. 2005. Nanomedicine: Current status and future prospects. FASEB J 19:311-330.
84. Moore A, Weissleder R, Bogdanov A Jr. 1997. Uptake of dextrancoated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging 7:1140-1145.
85. Moro L, Venturio M, Bozzo C, Silengo L, Altruda F, Beguinot L, Tarone G, Defilippi P. 1998. Integrins induce activation of EGF receptor: Role in MAP kinase induction and adhesion dependent cell survival. EMBO J 17:6622-6632.
86. Mukherjee S, Ghosh RN, Maxfield FR. 1997. Endocytosis. Physiol Rev 77:759-803.
87. Muro S, Mateescu M, Gajewski C, Robinson M, Muzykantov VR, Koval M. 2006. Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+ exchanger proteins. Am J Physiol Lung Cell Mol Physiol 290:L809-817.
88. Nakagawa Y, Wakuri S, Sakamoto K, Tanaka N. 1997. The photogenotoxicity of titanium dioxide particles. Mutat Res 394:125-132.
89. Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622-627.
90. Nucifora FC, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, et al. 2001. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 291:2423-2428.
91. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, et al.. 2005a. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part Fibre Toxicol 2:8.
92. Oberdörster G, Oberdorster E, Oberdorster J. 2005b. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839.
93. Panduri V, Weitzman SA, Chandel N, Kamp DW. 2003. The mitochondria-regulated death pathway mediates asbestos-induced alveolar epithelial cell apoptosis. Am J Respir Cell Mol Biol 28:241-248.
94. Pante N, Kann M. 2002. Nuclear pore complex is able to transport macromolecules with diameters of ∼39 nm. Mol Biol Cell 13:425-434.
95. Park JB. 2003. Phagocytosis induces superoxide formation and apoptosis in macrophages. Exp Mol Med 35:325-335.
96. Park S, Nam H, Chung N, Park JD, Lim Y. 2006. The role of iron in reactive oxygen species generation from diesel exhaust particles. Toxicol In Vitro 20:851-857.
97. Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J. 1997. Respiratory effects are associated with the number of ultrafine particles. Am J Respir Crit Care Med 155:1376-1383.
98. Porter AE, Muller K, Skepper J, Midgley P, Welland M. 2006. Uptake of C60 by human monocyte macrophages, its localization and implications for toxicity: studied by high resolution electron microscopy and electron tomography. Acta Biomater 2:409-419.
99. Pourazar J, Mudway IS, Samet JM, Helleday R, Blomsberg A, Wilson SJ, Frew AJ, Kelly FJ, Sandström T. 2005. Diesel exhaust activates redox-sensitive transcription factors and kinases in human airways. Am J Physiol Lung Cell Mol Physiol 289:L724-730.
100. Qaddoumi MG, Gukasyan HJ, Davda J, Labhasetwar V, Kim KJ, Lee VH. 2003. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: Role in PLGA nanoparticle endocytosis. Mol Vis 9:559-568.
101. Qi LF, Xu ZR, Li Y, Jiang X, Han XY. 2005. In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. World J Gastronenterol 11:5136-5141.
102. Rahman Q, Lohani M, Dopp E, Pemsel H, Jonas L, Weiss DG, Schiffmann D. 2002. Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts. Environ Health Perspect 110:797-800.
103. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. 2004. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: Mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 39:56-63.
104. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. 2004. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 377:159-169.
105. Renwick LC, Brown D, Clouter A, Donaldson K. 2004. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med 61:442-447.
106. Rogers WJ, Basu P. 2005. Factors regulating macrophage endocytosis of nanoparticles: Implications for targeted magnetic resonance plaque imaging. Atherosclerosis 178:67-73.
107. Roser M, Fischer D, Kissel T. 1998. Surface-modified biodegradable albumin nano- and microspheres. II: Effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm 46:255-263.
108. Ross CA, Pickart C. 2004. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases. Trends Cell Biol 14:703-711.
109. Roy I, Ohulchanskyy TY, Bharali DJ, Pudavar HE, Mistretta RA, Kaur N, Prasad PN. 2004. Optical tracking of organically modified nanoparticles as DNA carriers: A nonviral, nanomedicine approach for gene delivery. Proc Natl Acad Sci USA 102:279-284.
110. Salnikov VV, Lukyanenko YO, Frederick CA, Lederer WJ, Lukyanenko VI. 2006. Probing the Outer Mitochondrial Membrane in Cardiac Mitochondria with Nanoparticles. Biophys J 92:1058-1071.
111. Salvi SS, Nordenhall C, Blomberg A, Rudell B, Pourazar J, Kelly FJ, Wilson S, Sandström T, Holgate ST, Frew AJ. 2000. Acute Exposure to diesel exhaust increases IL-8 and GRO-α production in healthy human airways. Am J Respir Crit Care Med 161:550-557.
112. Satoh MS, Lindahl T. 1994. Enzymatic repair of oxidative DNA damage. Cancer Res 54:1899s-1901.
113. Savic R, Luo L, Eisenberg A, Maysinger D. 2003. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300:615-618.
114. Schins RPF. 2002. Mechanisms of genotoxicity of particles and fibres. Inhal Toxicol 14:57-78.
115. Schins RPF, Hei TK. 2006. Genotoxic effects of particles. In: Donaldson K, Borm P, Boca R, editors. Particle toxicology. New York: CRC Press/Taylor & Francis Group. p 285-298.
116. Schins RPF, Knaapen AM: Genotoxicity of poorly soluble particles. Inhal Toxicol, in press.
117. Scott CC, Botelho RJ, Grinstein S. 2003. Phagosome maturation: A few bugs in the system. J Membrane Biol 193:137-152.
118. Sera N, Tokiwa H, Miyata N. 1996. Mutagenicity of the fullerene C60-generated singlet oxygen dependent formation of lipid peroxides. Carcinogenesis 17:2163-2169.
119. Shi X, Mao Y, Daniel LN, Saffiotti U, Dalal NS, Vallyathan V. 1994. Silica radical-induced DNA damage and lipid peroxidation. Environ Health Perspect 102(Suppl. 10):149-154.
120. Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF. 2003. Apoptosis and lung cancer: A review. J Cell Biochem 88:885-898.
121. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M. 2005. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview. Langmuir 21:10644-10654.
122. Singh KK, Kulawiec M, Still I, Desouki MM, Geradts J, Matsui S. 2005. Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 354:140-146.
123. Speiser PP. 1991. Nanoparticles and liposomes: A state of the art. Methods Find Exp Clin Pharmacol 13:337-342.
124. Steinhauser I, Spankuch B, Strebhardt K, Langer K. 2006. Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. Biomaterials 27:4975-4983.
125. Stoeger T, Reinhard C, Takenaka S, Schroeppel A, Karg E, Ritter B, Heyder J, Schulz H. 2006. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect 114:328-333.
126. Sydlik U, Bierhals K, Soufi M, Abel J, Schins RPF, Unfried K. 2006. Ultrafine carbon particles induce apoptosis and proliferation in rat lung epithelial cells via specific signaling pathways both using EGF-R. Am J Physiol Lung Cell Mol Physiol 291:725-733.
127. Takenaka S, Karg E, Kreyling WG, Lentner B, Moller W, Behnke-Semmler M, Jennen L, Walch A, Michalke B, Schramel P, et al. 2006. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol 18:733-740.
128. Takenaka S, Karg E, Roth Ch, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environm Health Persp 109(Suppl. 4):547-551.
129. Tamaoki J, Isono K, Takeyama K, Tagaya E, Nakata J, Nagai A. 2004. Ultrafine carbon black particles stimulate proliferation of human airway epithelium via EGF-R. Am J Physiol Lung Cell Mol Physiol 287:1127-1133.
130. Tiera MJ, Winnik FO, Fernandes JC. 2006. Synthetic and natural polycations for gene therapy: State of the art and new perspectives. Curr Gene Ther 6:59-61.
131. Timblin CR, Shukla A, Berlanger I, BeruBe KA, Churg A, Mossman BT. 2002. Ultrafine airborne particles cause increases in protooncogene expression and proliferation in alveolar epithelial cells. Toxicol Appl Pharmacol 179:98-104.
132. Tkachenko AG, Xie H, Liu Y, Coleman D, Ryan J, Glomm WR, Shipton MK, Franzen S, Feldheim DL. 2004. Cellular trajectories of peptide-modified gold particle complexes: Comparison of nuclear localization signals and peptide transduction domains. Bioconjug Chem 15:482-490.
133. Tornaletti S. 2005. Transcription arrest at DNA damage sites. Mutat Res 577:131-145.
134. Tran HP, Prakash AS, Barnard R, Chiswell B, Ng JC. 2002. Arsenic inhibits the repair of DNA damage induced by benzo(a)pyrene. Toxicol Lett 133:59-67.
135. Upadhyay D, Kamp DW. 2003. Asbestos-induced pulmonary toxicity: Role of DNA damage and apoptosis. Exp Biol Med (Maywood) 228:650-659.
136. Vijayanathan V, Thomas T, Thomas TJ. 2002. DNA nanoparticles and development of DNA delivery vehicles for gene therapy. Biochemistry 41:14086-14094.
137. Vinzents PS, Moller P, Sorensen M, Knudsen LE, Hertel O, Jensen FP, Schibye B, Loft S. 2005. Personal exposure to ultrafine particles and oxidative DNA damage. Environ Health Perspect 113:1485-1490.
138. von Mikecz A. 2006. The nuclear ubiquitin-proteasome system. J Cell Sci 119:1977-1984.
139. Wilson MR, Lightbody JH, Donaldson K, Sales J, Stone V. 2002. Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxicol Appl Pharmacol 184:172-179.
140. Wiseman H, Halliwell B. 1996. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J 313:17-29.
141. Wong HL, Bendayan R, Rauth AM, Xue HY, Babakhanian K, Wu XY. 2006. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. J Pharmacol Exp Ther 317:1372-1381.
142. Xia T, Korge P, Weiss JN, Li N, Venkatesen MI, Sioutas C, Nel A. 2004. Quinones and aromatic chemical compounds in particulate matter induce mitochondrial dysfunction: Implications for ultrafine particle toxicity. Environ Health Perspect 112:1347-1358.
143. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE. 2006. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6:1794-1807.
144. Xing X, He X, Peng J, Wang K, Tan W. 2005. Uptake of silicacoated nanoparticles by HeLa cells. J Nanosci Nanotechnol 5:1688-1693.
145. Xu A, Wu LJ, Santella RM, Hei TK. 1999. Role of oxyradicals in mutagenicity and DNA damage induced by crocidolite asbestos in mammalian cells. Cancer Res 59:5922-5926.
146. 1O2. J Am Chem Soc 125:12803-12809.
147. Zhang Q, Kleeberger SR, Reddy SP. 2003. DEP-induced fra-1 expression correlates with a distinct activation of AP-1-dependent gene transcription in the lung. Am J Physiol Lung Cell Lol Physiol 286:L427-436.
148. Zhang Y, Kohler N, Zhang M. 2002. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23:1553-1561.
149. Zhou BB, Elledge SJ. 2000. The DNA damage response: Putting checkpoints in perspective. Nature 408:433-439.
150. Zhu Y, Zhao Q, Li Y, Cai X, Li W. 2006. The interaction and toxicity of multi-walled carbon nanotubes with Stylonychia mytilus. J Nanosci Nanotech 6:1357-1364.